This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) To 2017: Global Analysis

Figure 5 1: Global – PCR Based Test Market (Million US$), 2010 – 2012Figure 5 2: Global – Forecast for PCR Based Test Market (Million US$), 2013 – 2017Figure 5 3: Global – PCR Related Technologies Market (Million US$), 2010 – 2012Figure 5 4: Global – Forecast for PCR Related Technologies Market (Million US$), 2013 – 2017Figure 5 5: Global – Non-PCR Test Market (Million US$), 2010 – 2012Figure 5 6: Global – Forecast for Non-PCR Test Market (Million US$), 2013 – 2017Figure 5 7: Global – Fish & Innovations Market (Million US$), 2010 – 2012Figure 5 8: Global – Forecast for Fish & Innovations Market (Million US$), 2013 – 2017Figure 5 9: Global – Biochips/ Microarrays Market (Million US$), 2010 – 2012Figure 5 10: Global – Forecast for Biochips/Micrroarrays Market (Million US$), 2013 – 2017Figure 5 11: Global – Biosensors Market (Million US$), 2010 – 2012Figure 5 12: Global – Forecast for Biosensors Market (Million US$), 2013 – 2017Figure 5 13: Global – Molecular Imaging Market (Million US$), 2010 – 2012Figure 5 14: Global – Forecast for Molecular Imaging Market (Million US$), 2013 – 2017Figure 5 15: Global – Other Technologies Market (Million US$), 2010 – 2012Figure 5 16: Global – Forecast for Other Technologies Market (Million US$), 2012 – 2017

Figure 6 1: US – Molecular Diagnostics Market (Million US$), 2002 – 2012Figure 6 2: US – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 3: Europe – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 5: China – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 6: China – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 7: Japan – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 8: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 9: India – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 10: India – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 11: Brazil – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6 12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 13: Mexico – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6 14: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 15: South Korea – Molecular Diagnostics Market (Million US$), 2005 – 2012Figure 6 16: South Korea – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 17: Rest of World – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 18: Rest of World – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017

Figure 7 1: Roche – Molecular Diagnostics Sales (Million US$), 2008 – 2012Figure 7 2: Roche – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 3: Abbott – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 4: Abbott – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 5: Myriad Genetics – Molecular Diagnostics Sales (Million US$), 2007 – 2012Figure 7 6: Myriad Genetics – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 7: Qiagen – Molecular Diagnostics Sales (Million US$), 2009 – 2012Figure 7 8: Qiagen – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 9: BioMérieux – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 10: BioMérieux – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 11: Other Companies – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 12: Other Companies – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017

6 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs